65 patienter med bipolær sygdom blev forbundet med en stigning på ≥% af baseline legemsvægt hos 7 39, 9% af patienterne.
Long-term olanzapine treatment (up to 12 months) for recurrence prevention in patients with bipolar disorder was associated with an increase of  from baseline body weight in 39.9% of 7% patients.